Depression: Turning to Ketamine Therapy Before Antidepressants

There is a very real concern in the United States that doctors are overprescribing antidepressant medications to their patients. AARP mentions that prescribing meds “without a diagnosis of depression is escalating” especially among the elderly population. Most often, medications are prescribed by a primary care physician or a psychiatrist for depression and mood disorders. Common …

Read more

Addiction and Ketamine – How Ketamine Helps with Addiction

Are you suffering from alcohol or substance abuse? If so, you’re not alone, and ketamine therapy may be able to help. According to the National Institute on Alcohol Abuse and Alcoholism’s 2015 study, “15.1 million adults 18 and older (6.2% of this age group) had AUD (Alcohol Use Disorder). The Mayo Clinic defines AUD as …

Read more

A Single Dose Of Ketamine Might Help Heavy Drinkers, Study Finds

The research team recruited 90 people who drank much more than average — an average of about four to five pints of beer a day, or about five times the U.K.’s recommended maximum — but had not previously been diagnosed with alcoholism and were not receiving treatment. On the first day of the experiment, participants …

Read more

Ketamine for Depression: Does it work?

What is Ketamine? Ketamine, also known as Ketalar, Ketaset, and Ketanest, is a medication that’s currently FDA approved only as an anesthetic but it’s showing great potential as a treatment for severe depression. In fact, numerous Ketamine Clinics have begun to appear throughout the United States to solve this problem. Depressed patients with stubborn symptoms get relief …

Read more

Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature

Abstract Anxiety disorders are among the most prevalent psychiatric conditions. Despite many proven pharmacological and non-pharmacological treatments available, high rates of partial response and low rates of long-term remission remain. Ketamine has been receiving increasing attention as an interventional treatment modality in psychiatry, especially among refractory conditions, including major depressive disorder. There is limited yet growing …

Read more

Remission From Behavioral Dysregulation in a Child With PTSD After Receiving Procedural Ketamine

Abstract Ketamine, an N-methyl-D-aspartate–type glutamate receptor antagonist, has long been used for anesthesia and has recently been investigated for its rapid antidepressant effects in adults with treatment-resistant depression and posttraumatic stress disorder (PTSD). We report a case of a child with PTSD and episodes of severe aggression and emotional dysregulation that were refractory to multiple …

Read more

Ketamine research reports 75% success rate in treatment of long-term depression

Researchers looking into the use of ketamine say they have had a 75 per cent success rate in using it to treat long-term depression. “The results are startling,” says Melbourne University neuroscientist Associate Professor Graham Barrett, who has been studying depression for 30 years. “They’re not 100 per cent, there are people who don’t respond …

Read more

Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study

Background Chronic pain is common in children and adolescents and is often associated with severe functional disability and mood disorders. The pharmacological treatment of chronic pain in children and adolescents can be challenging, ineffective, and is mostly based on expert opinions and consensus. Ketamine, an N-methyl-D-aspartate receptor antagonist, has been used as an adjuvant for …

Read more

How much ketamine is the right dosage for Treatment Resistant Depression?

Abstract Numerous placebo-controlled studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to induce rapid (within hours), transient antidepressant effects when administered intravenously (IV) at subanesthetic doses (0.5 mg/kg over 40 min). However, the optimal antidepressant dose remains unknown. We aimed to compare to active placebo the rapid acting antidepressant properties of a …

Read more

(833) 867-2329

Get Help Today!

Contact Us